Goodwin Procter advised Asher Biotherapeutics on the deal.Asher Biotherapeutics announced the closing of its Series B financing, which raised $108 million. The financing was led by Wellington…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now